Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals

Virology

Volumn 350, Issue 1, 2006, Pages 128-136

  Sharma, Madeva C ^a   Zhou, Wendy ^a   Martinez, Joy ^a   Krymskaya, Ludmila ^a   Srivastava, Tumul ^a   Haq, Wahajul ^a   Diamond, Don J ^a   Lacey, Simon F ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

BK virus; Cytotoxic T lymphocytes; JC virus; polyomavirus

Indexed keywords

EPITOPE; HLA A ANTIGEN; POLYPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BK VIRUS; CELLULAR IMMUNITY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; FLOW MEASUREMENT; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOCOMPETENCE; JC VIRUS; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN ANALYSIS; SEQUENCE HOMOLOGY; SURVIVAL TIME; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINIA;

ANIMALS; BK VIRUS; CAPSID PROTEINS; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; IMMUNOCOMPETENCE; JC VIRUS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

BK POLYOMAVIRUS; JC POLYOMAVIRUS; MUS MUSCULUS; POLYOMAVIRUS;

EID: 33744899879     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.02.040     Document Type: Article

References (36)

1. Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J., Ploegh H.L., Peterson P.A., Yang Y., and Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6 (1997) 613-621
2. + T-cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8 (2002) 379-385
3. + T-cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281 (2003) 65-78
4. Chesters P.M., Heritage J., and McCance D.J. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J. Infect. Dis. 147 (1983) 676-684
5. + T-cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J. Clin. Invest. 115 (2005) 3602-3612
6. Comoli P., Basso S., Azzi A., Moretta A., De Santis R., Del Galdo F., De Palma R., Valente U., Nocera A., Perfumo F., Locatelli F., Maccario R., and Ginevri F. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J. Am. Soc. Nephrol. 14 (2003) 3197-3204
7. Comoli P., Azzi A., Maccario R., Basso S., Botti G., Basile G., Fontana I., Labirio M., Cometa A., Poli F., Perfumo F., Locatelli F., and Ginevri F. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78 (2004) 1229-1232
8. Daftarian P., Ali S., Sharan R., Lacey S.F., La Rosa C., Longmate J., Buck C., Siliciano R.F., and Diamond D.J. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T-cells and clears vaccinia virus challenge. J. Immunol. 171 (2003) 4028-4039
9. Dorries K., Vogel E., Gunther S., and Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198 (1994) 59-70
10. Drummond J.E., Shah K.V., and Donnenberg A.D. Cell-mediated immune responses to BK virus in normal individuals. J. Med. Virol. 17 (1985) 237-247
11. Drummond J.E., Shah K.V., Saral R., Santos G.W., and Donnenberg A.D. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients. J. Med. Virol. 23 (1987) 331-344
12. Du Pasquier R.A., Clark K.W., Smith P.S., Joseph J.T., Mazullo J.M., DE Girolami U., Letvin N.L., and Koralnik I.J. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J. NeuroVirol. 7 (2001) 318-322
13. Du Pasquier R.A., Kuroda M.J., Schmitz J.E., Zheng Y., Martin K., Peyerl F.W., Lifton M., Gorgone D., Autissier P., Letvin N.L., and Koralnik I.J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J. Virol. 77 (2003) 11918-11926
14. Du Pasquier R.A., Kuroda M.J., Zheng Y., Jean-Jacques J., Letvin N.L., and Koralnik I.J. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127 (2004) 1970-1978
15. Du Pasquier R.A., Schmitz J.E., Jean-Jacques J., Zheng Y., Gordon J., Khalili K., Letvin N.L., and Koralnik I.J. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J. Virol. 78 (2004) 10206-10210
16. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10 (1996) F17-F22
17. Firat H., Garcia-Pons F., Tourdot S., Pascolo S., Scardino A., Garcia Z., Michel M.L., Jack R.W., Jung G., Kosmatopoulos K., Mateo L., Suhrbier A., Lemonnier F.A., and Langlade-Demoyen P. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur. J. Immunol. 29 (1999) 3112-3121
18. +. Int. Immunol. 11 (1999) 1027-1033
19. Jones T.R., and Sun L. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71 (1997) 2970-2979
20. Jones T.R., Wiertz E.J., Sun L., Fish K.N., Nelson J.A., and Ploegh H.L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11327-11333
21. Kim S.K., Cornberg M., Wang X.Z., Chen H.D., Selin L.K., and Welsh R.M. Private specificities of CD8 T-cell responses control patterns of heterologous immunity. J. Exp. Med. 201 (2005) 523-533
22. Kleinschmidt-DeMasters B.K., and Tyler K.L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353 (2005) 369-374
23. Knowles W.A. The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In: Khalili K., and Stoner G.L. (Eds). Human Polyomaviruses: Molecular and Clinical Perspectives (2001), Wiley-Liss 527-559
24. Knowles W.A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D.W., and Miller E. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71 (2003) 115-123
25. + progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J. Immunol. 168 (2002) 499-504
26. Kotenko S.V., Saccani S., Izotova L.S., Mirochnitchenko O.V., and Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1695-1700
27. Krausa P., and Browning M.J. A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles. Tissue Antigens 47 (1996) 237-244
28. Krymskaya L., Sharma M.C., Martinez J., Haq W., Huang E.C., Limaye A.P., Diamond D.J., and Lacey S.F. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J. Virol. 79 (2005) 11170-11178
29. La Rosa C., Krishnan R., Markel S., Schneck J.P., Houghten R., Pinilla C., and Diamond D.J. Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. Blood 97 (2001) 1776-1786
30. La Rosa C., Wang Z., Brewer J.C., Lacey S.F., Villacres M.C., Sharan R., Krishnan R., Crooks M., Markel S., Maas R., and Diamond D.J. Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice. Blood 100 (2002) 3681-3689
31. Langer-Gould A., Atlas S.W., Green A.J., Bollen A.W., and Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353 (2005) 375-381
32. Lin M.Y., and Welsh R.M. Stability and diversity of T-cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J. Exp. Med. 88 (1998) 1993-2005
33. Maecker H.T., Moon J., Bhatia S., Ghanekar S.A., Maino V.C., Payne J.K., Kuus-Reichel K., Chang J.C., Summers A., Clay T.M., Morse M.A., Lyerly H.K., DeLaRosa C., Ankerst D.P., and Disis M.L. Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol. 6 (2005) 17
34. + cytotoxic T lymphocytes in HIV-infected patients. J. Exp. Med. 200 (2004) 1407-1417
35. + T-cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J. Infect. Dis. 182 (2000) 451-458
36. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., and Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84 (1996) 769-779